2018
DOI: 10.1007/s00520-018-4101-9
|View full text |Cite
|
Sign up to set email alerts
|

25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it?

Abstract: The prevalence of 25(OH)D deficiency in the analyzed group of patients with lymphoid malignancies is high and greater in malnourished individuals. Patients with pretreatment serum 25(OH)D < 19.6 nmol/l had a significantly shorter PFS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(15 citation statements)
references
References 30 publications
0
15
0
Order By: Relevance
“…Vitamin D de ciency is also common in lymphoma patients. Previous studies have shown that when the threshold was set at 50 nmol/L, the vitamin D de ciency rate ranged from 67%-88% [11,23], which mainly among B-cell lymphoma. And the prognostic ability of 25-(OH)D in these B-cell tumors such as mantle cell lymphoma, chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and diffuse large B-cell lymphoma (DLBCL) has also been demonstrated [11][12][13][14][15]24].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Vitamin D de ciency is also common in lymphoma patients. Previous studies have shown that when the threshold was set at 50 nmol/L, the vitamin D de ciency rate ranged from 67%-88% [11,23], which mainly among B-cell lymphoma. And the prognostic ability of 25-(OH)D in these B-cell tumors such as mantle cell lymphoma, chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and diffuse large B-cell lymphoma (DLBCL) has also been demonstrated [11][12][13][14][15]24].…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have shown that when the threshold was set at 50 nmol/L, the vitamin D de ciency rate ranged from 67%-88% [11,23], which mainly among B-cell lymphoma. And the prognostic ability of 25-(OH)D in these B-cell tumors such as mantle cell lymphoma, chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and diffuse large B-cell lymphoma (DLBCL) has also been demonstrated [11][12][13][14][15]24]. Until now, few studies have reported the relationship between vitamin D de ciency and the prognosis of T-cell lymphoma [14,16], and only one study included ENKTL patients, in which 38.6% of the ENKTL patients had below 10 ng/mL (25 nmol/L) of 25-(OH)D at diagnosis [16].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In terms of lymphoma, although studies have suggested that ultraviolet radiation has a protective effect on the development of lymphoma [6,7], but 25-(OH)D has no signi cant effect on the risk of lymphoma [6][7][8][9][10]. Nonetheless, several studies have shown that 25-(OH)D is signi cant in the prognostic evaluation of lymphoma [11][12][13][14][15]. Therefore, 25-(OH)D may be a good prognostic factor in lymphoma.…”
Section: Introductionmentioning
confidence: 99%
“…In human medicine, although the cause and effect relationship is not proven, the relationship between vitamin D status and diseases unrelated to bone metabolism has been extensively studied in recent years, and lower vitamin D concentrations has been associated with increased cancer incidence (Djurasinović et al, 2018;Yin et al, 2013); cardiovascular diseases, such as myocardial infarction (Giovannucci, Liu, Hollis, & Rimm, 2008), stroke and heart failure (Chowdhury et al, 2012;Muscogiuri et al, 2017), as well as autoimmune diseases (e.g., diabetes mellitus type I) (Pludowski et al, 2013), multiple sclerosis (Martinelli et al, 2014), rheumatoid arthritis (Kerr et al, 2011) and infectious diseases (White, 2008).…”
Section: Introductionmentioning
confidence: 99%